Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators.
We previously reported that taurine chloramine (TauCl), a product of activated neutrophils, inhibits the generation of macrophage inflammatory mediators such as nitric oxide (NO), TNF-alpha, and PGE2. Taurine, the most abundant free amino acid in the cytosol of neutrophils, is chlorinated to form TauCl by the halide-dependent myeloperoxidase (MPO) system. Under physiological conditions, TauCl reduces HOCl toxicity. In this study, we investigated the influence of TauCl on generation of oxygen free radicals, cytokines and eicosanoids by activated murine peritoneal neutrophils. We found that TauCl, but not taurine alone, inhibited the production of NO, prostaglandin E2, interleukin-6 and tumor necrosis factor-alpha, in a dose-dependent manner. In contrast, the products of the respiratory burst, as measured by luminol-dependent chemiluminescence (LCL), were reduced by both taurine and TauCl. However, taurine affected LCL at higher concentrations and to a lesser extent than TauCl. The results of these studies suggest that TauCl decreases production of tissue-damaging inflammatory mediators and may regulate the balance between protective, microbicidal and toxic effect of neutrophils.
Marcinkiewicz
J
J
Department of Immunology, Jagiellonian University Medical College, Cracow, Poland.
Grabowska
A
A
Bereta
J
J
Bryniarski
K
K
Nowak
B
B
D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D015232:Dinoprostone / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D015777:Eicosanoids / Q000378:metabolism; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008163:Luminescent Measurements; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009569:Nitric Oxide / Q000037:antagonists & inhibitors; D013481:Superoxides / Q000378:metabolism; D013654:Taurine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D000093242:Interleukin-6 Inhibitors
D016207:Cytokines; D015232:Dinoprostone; D015777:Eicosanoids; D018836:Inflammation Mediators; D009569:Nitric Oxide; D013481:Superoxides; D013654:Taurine; D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors; C043410:N-chlorotaurine